Technical Analysis for ORPHY - Orphazyme A/S ADR

Grade Last Price % Change Price Change
B 0.2351 -2.49% -0.0060
ORPHY closed up 2.99 percent on Friday, May 13, 2022, on 61 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A N/A Down

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup -2.49%
Lower Bollinger Band Walk Weakness -2.49%
Wide Bands Range Expansion -2.49%
Gapped Up Strength -2.49%
Lower Bollinger Band Touch Weakness -2.49%
Oversold Stochastic Weakness -2.49%
Lower Bollinger Band Walk Weakness 0.43%
New 52 Week Low Weakness 0.43%
Outside Day Range Expansion 0.43%
Wide Bands Range Expansion 0.43%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 4 hours ago
Down 5% about 4 hours ago
Down 3% about 4 hours ago
Up 3% about 4 hours ago
Lower Bollinger Band Support about 4 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Life Sciences Biopharmaceutical Diseases Neurological Disorders Degenerative Disease Neurodegenerative Disease Type C Rare Diseases Amyotrophic Lateral Sclerosis Orphan Diseases Senescence Gaucher Disease Amyloidosis Arimoclomol Inclusion Body Myositis Lipid Storage Disorders Lysosomal Dysfunction Niemann Niemann Pick Disease Niemann–Pick Disease

Is ORPHY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.7197
52 Week Low 0.2103
Average Volume 120,919
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.3051
10-Day Moving Average 0.2733
Average True Range 0.0643
RSI 24.24
ADX 69.02
+DI 6.0084
-DI 24.3336
Chandelier Exit (Long, 3 ATRs) 0.2071
Chandelier Exit (Short, 3 ATRs) 0.4032
Upper Bollinger Bands 0.3971
Lower Bollinger Band 0.2131
Percent B (%b) 0.15
BandWidth 60.3081
MACD Line -0.0629
MACD Signal Line -0.0548
MACD Histogram -0.0081
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3752
Resistance 3 (R3) 0.3799 0.3399 0.3529
Resistance 2 (R2) 0.3399 0.3057 0.3376 0.3454
Resistance 1 (R1) 0.2905 0.2847 0.2705 0.2858 0.3379
Pivot Point 0.2505 0.2505 0.2405 0.2482 0.2505
Support 1 (S1) 0.2011 0.2163 0.1811 0.1964 0.1443
Support 2 (S2) 0.1611 0.1953 0.1588 0.1368
Support 3 (S3) 0.1117 0.1611 0.1294
Support 4 (S4) 0.1070